ArticleBiosensors2025
Numerical Study of a Novel Kagome-Inspired Photonic Crystal Fiber-Based Surface Plasmon Resonance Biosensor for Detection of Blood Components and Analytical Targets.
Article in Biosensors, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
7 citing papers in PubMed.
- Label-Free Refractive-Index-Based Detection of Breast, Leukemia, and Prostate Cancer Cells Using a Tetra-Core PCF SPR Biosensor.Biosensors · 2026Article
- U-shaped fiber-optic biosensor with gold nanoparticle-assisted signal amplification for allergy-related biomarker detection.Analytical and bioanalytical chemistry · 2026Article
- Performance improvement of an Au and TiONanoscale advances · 2026Article
- Design and optimization of highly sensitive and tunable nanostructure biosensor for heavy metal detection using machine learning.Discover nano · 2026Article
- Graphene-enhanced non-Hermitian Thue-Morse metamaterial sensor exploiting exceptional point for cancer biomarker detection.Scientific reports · 2026Article
- SPR biosensor with a graphene overlayer for carcinoma detection.Frontiers in bioengineering and biotechnology · 2026Article
- Theoretical Investigation of Early Cancer Biomarker Sensing Using a PMMA-Gold Hybrid Quasi-D-Shaped Photonic-Crystal-Fiber-Based Surface Plasmon Resonance Biosensor.Micromachines · 2025Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
This numerical study introduces a surface plasmon resonance (SPR)-based biosensor utilizing a kagome lattice-inspired hollow core photonic crystal fiber (PCF) for the highly sensitive detection of various blood biomarkers and analytical components. The sensor is designed to detect key blood biomarkers such as water, glucose, plasma, and hemoglobin (Hb), as well as analytical targets including krypton, sylgard, ethanol, polyacrylamide (PA), and bovine serum albumin (BSA), by monitoring shifts in the resonance wavelength (RW). A dual-polarization approach is employed by analyzing both transverse magnetic (TM) and transverse electric (TE) modes. The proposed sensor demonstrates exceptional performance, achieving maximum wavelength sensitivities (
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.